Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedNo longer looking for participants indicates recruitment has ended. The history adds Revision: v3.6.0 and removes Revision: v3.5.5 from the record.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page history now shows Revision: v3.5.5 as the latest version, replacing the previous v3.5.4.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page footer now shows Revision: v3.5.4, indicating the site was updated to a newer release.SummaryDifference0.0%

- Check57 days agoChange DetectedA new revision entry, v3.5.3, has been added to the history and the previous entry, v3.5.2, has been removed, updating the record of the page revisions.SummaryDifference0.0%

- Check71 days agoChange DetectedFooter now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision history updated to include Revision: v3.5.0 and remove Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.